CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ISU Abxis Company Limited Company Snapshot
ISU Abxis Company Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares ISU Abxis Company Limited with three other companies in this sector in South Korea: Corestem Inc (2017 sales of 18.09 billion Korean Won [US$16.03 million] of which 85% was The clinical trial agent), Alteogen Inc (12.10 billion Korean Won [US$10.72 million] ), and Cellumed Co Ltd (21.61 billion Korean Won [US$19.15 million] ).

Sales Analysis. ISU Abxis Company Limited reported sales of 19.46 billion Korean Won (US$17.24 million) for the year ending December of 2017. This represents an increase of 2.1% versus 2016, when the company's sales were 19.05 billion Korean Won. This was the third consecutive year of growth at ISU Abxis Company Limited. Sales of Antibody Medicine saw an increase of 3.8% in 2017, from 18.74 billion Korean Won to 19.45 billion Korean Won. Not all segments of ISU Abxis Company Limited experienced an increase in sales in 2017: sales of Other fell 95.8% to 13.37 million Korean Won. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ISU Abxis Company Limited
  Stock Performance Chart for ISU Abxis Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 7,610.00
(Figures in Korean Won)
1 Week -0.5%   13 Weeks -8.5%  
4 Weeks -32.4%   52 Weeks 3.4%  
 
ISU Abxis Company Limited Key Data:
  Ticker: 086890 Country: Korea (South)
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 19,458,889,863
(Year Ending Jan 2018).
Employees: 138
  Currency: Korean Won Market Cap: 198,270,612,770
  Fiscal Yr Ends: December Shares Outstanding: 26,053,957
  Share Type: Common Closely Held Shares: 9,916,109
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.